Medtronic (MDT) files Form 25 to delist from NYSE, File 001-36820

Medtronic plc (MDT) appears on a Form 25 notification indicating the class of securities is being removed from listing and/or registration on the New York Stock Exchange LLC.

Rhea-AI Filing Summary

Medtronic plc (MDT) appears on a Form 25 notification indicating the class of securities is being removed from listing and/or registration on the New York Stock Exchange LLC. The filing identifies the issuer's principal office at 710 Medtronic Pkwy, Minneapolis, MN and includes the Commission File Number 001-36820. The form cites compliance with 17 CFR 240.12d2-2 provisions for withdrawal or removal. The document provides no explanation of timing, underlying transaction, or impact on shareholders.

Positive

• Form 25 is filed, indicating procedural compliance with NYSE and SEC rules
• Issuer identity and principal office are clearly disclosed (Medtronic plc, Minneapolis address)

Negative

• Filing provides no reason for removal or whether the withdrawal is voluntary or exchange-initiated
• Document lacks effective date, impact on trading, and any shareholder instructions
• No financial metrics, transaction terms, or disclosures of material impact are included

Insights

Exchange Compliance Analyst

TL;DR: Form 25 notifies delisting action but gives no reason or timing.

The filing shows the NYSE has completed the procedural step to remove a security under 17 CFR 240.12d2-2. This is an administrative notice that the Exchange and issuer have followed listed rules.

Because the document contains no dates for effective removal, transaction details, or shareholder instructions, it does not by itself explain the business rationale or near-term market effects.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Medtronic's (MDT) Form 25 notify?

The filing notifies the removal/withdrawal of a class of Medtronic securities from the New York Stock Exchange under 17 CFR 240.12d2-2.

Does the Form 25 state why MDT is being delisted?

No. The document does not provide a reason, effective date, or explanation for the removal.

What identifier is listed on the filing for Medtronic?

The filing includes the Commission File Number 001-36820 for the issuer.

Is there any trading or shareholder guidance in this Form 25?

No. The form contains no guidance on trading suspension, shareholder actions, or timelines.

Which SEC rule provisions does the Form 25 reference?

It cites 17 CFR 240.12d2-2 and references compliance under the Exchange's procedures for withdrawal or striking from listing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/29/2025 - 10:44 AM Learn about SEC filing dates

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-36820

Issuer:	Medtronic plc
Exchange:	NEW YORK STOCK EXCHANGE LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	710 Medtronic Pkwy
	Minneapolis	MINNESOTA	55432
Telephone number:					(763) 514-4000

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Guarantor of 2.625% Senior Notes due 2025

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, NEW YORK STOCK EXCHANGE LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-09-29	By	Tyler Mastronardi		Analyst, Market Watch
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.